Burrill & Co.

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.
By a GenomeWeb staff reporter

Under the agreement, the two companies will co-invest into life science opportunities in China.

The building, estimated to cost $6 million, would include space configurable for either laboratory or light industrial use, designed for life-sci users that do not need the intensive use of utilities available in more traditional lab buildings.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.